Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese
Clinical trial NCT01679028 · COMPLETED
Trial details
- NCT number
- NCT01679028
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2012-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.